Detalles de la búsqueda
1.
The real-world outcomes of Lutetium-177 PSMA-617 radioligand therapy in metastatic castration-resistant prostate cancer: Turkish Oncology Group multicenter study.
Int J Cancer
; 154(4): 692-700, 2024 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37818966
2.
Neoadjuvant Chemotherapy and Pathologic Complete Response in HR+/HER2- Breast Cancer: Impact of Tumor Ki67 and ER Status.
Chemotherapy
; 2024 Feb 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38368871
3.
Real-world evaluation of nivolumab in patients with non-nasopharyngeal recurrent or metastatic head and neck cancer: a retrospective multi-center study by the Turkish Oncology Group (TOG).
Eur Arch Otorhinolaryngol
; 2024 May 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38795147
4.
Outcomes of surveillance versus adjuvant treatment for patients with stage-I seminoma: a single-center experience.
World J Urol
; 41(8): 2201-2207, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37351618
5.
Real-life experience of patients with sarcomatoid renal cell carcinoma: a multicenter retrospective study.
Neoplasma
; 70(1): 158-165, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36620878
6.
Impact of Skeletal Muscle Measurements by Chest Computed Tomography on Survival and Postoperative Complications in Patients with Soft Tissue Sarcoma.
Nutr Cancer
; 74(7): 2499-2507, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35416100
7.
Real-world assessment of quality-of-life in patients with breast cancer treated with adjuvant endocrine therapy.
Future Oncol
; 18(22): 2425-2439, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35695547
8.
Immunogenicity and safety of the CoronaVac vaccine in patients undergoing treatment for breast and lung cancer.
Bratisl Lek Listy
; 123(6): 401-407, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35576541
9.
Prognostic factors of perioperative FLOT regimen in operable gastric and gastroesophageal junction tumors: real-life data (Turkish Oncology Group).
Turk J Med Sci
; 52(4): 1022-1032, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-36326360
10.
Efficacy and Safety of Trastuzumab Emtansine in Her2 Positive Metastatic Breast Cancer: Real-World Experience.
Cancer Invest
; 39(6-7): 473-481, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34014777
11.
Modified Glasgow Prognostic Score, Prognostic Nutritional Index and ECOG Performance Score Predicts Survival Better than Sarcopenia, Cachexia and Some Inflammatory Indices in Metastatic Gastric Cancer.
Nutr Cancer
; 73(2): 230-238, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-32270713
12.
Prognostic factors in progressive high-grade glial tumors treated with systemic approach: A single center experience.
J Oncol Pharm Pract
; 27(2): 329-339, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-32349641
13.
Comparison of three different chemotherapy regimens for concomitant chemoradiotherapy in locally advanced non-small cell lung cancer.
Int J Clin Oncol
; 25(12): 2015-2024, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32797321
14.
Worse patient-physician relationship is associated with more fear of cancer recurrence (Deimos Study): A study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG).
Eur J Cancer Care (Engl)
; 29(6): e13296, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32864838
15.
How long should we continue crizotinib in ALK translocation-positive inflammatory myofibroblastic tumors? Long-term complete response with crizotinib and review of the literature.
J Oncol Pharm Pract
; 26(4): 1011-1018, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-31615346
16.
A rare case of primary rectal choriocarcinoma and review of the literature.
J Oncol Pharm Pract
; 26(4): 989-994, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-31547751
17.
Impact of the Charlson Comorbidity Index on dose-limiting toxicity and survival in locally advanced and metastatic renal cell carcinoma patients treated with first-line sunitinib or pazopanib.
J Oncol Pharm Pract
; 26(5): 1147-1155, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31793376
18.
Is insulin resistance a predictor for complete response in breast cancer patients who underwent neoadjuvant treatment?
World J Surg Oncol
; 18(1): 242, 2020 Sep 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32907593
19.
Tumor budding for predicting prognosis of resected rectum cancer after neoadjuvant treatment.
World J Surg Oncol
; 17(1): 50, 2019 Mar 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-30871581
20.
Changes in 18F-FDG-PET/CT tumor metabolism are not consistent with pathologic complete response in hormone-positive breast cancer.
J BUON
; 22(5): 1191-1198, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29135102